• Nenhum resultado encontrado

[PDF] Top 20 Nanoparticles for recognition and delivery in metastatic colorectal cancer cells

Has 10000 "Nanoparticles for recognition and delivery in metastatic colorectal cancer cells" found on our website. Below are the top 20 most common "Nanoparticles for recognition and delivery in metastatic colorectal cancer cells".

Nanoparticles for recognition and delivery in metastatic colorectal cancer cells

Nanoparticles for recognition and delivery in metastatic colorectal cancer cells

... Colorectal cancer is a global health concern. The high incidence of colorectal metastasis, mainly in the liver, triggers an increase of the mortality rate and greatly reduces the ... See full document

72

pH-sensitive nanomicelles for controlled and efficient drug delivery to human colorectal carcinoma LoVo cells.

pH-sensitive nanomicelles for controlled and efficient drug delivery to human colorectal carcinoma LoVo cells.

... drug delivery and intracellular drug release triggered by ...(P(Asp-DIP)) and poly (lysine-cholic acid) ...PTX and SPIO in aqueous solution at neutral pH, and disassembles ... See full document

9

EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.

EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.

... observed in several types of cancers and is called ‘elevated micro- satellite alterations at selected tetranucleotide repeats’ (EMAST) in contrast to mono-, and di- nucleotide based ... See full document

13

Gold nanoparticles for targeting varlitinib to human pancreatic cancer cells

Gold nanoparticles for targeting varlitinib to human pancreatic cancer cells

... problem in the cancer treatments with chemotherapeutic agents has been the high toxicity and low bioavailability of the anticancer ...heterogeneity and the MDR are the key challenge in ... See full document

12

Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer

Perioperative tumor cell dissemination in patients with primary or metastatic colorectal cancer

... of cells and enables the immunophenotypic character- ization of each cell in the ...disease in hematolog- ical malignant neoplasms 17,19,23,24 and, more recently, an important tool ... See full document

5

Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer

Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer

... against cancer targets the several phases of the cell cycle, thereby interfering in cell growth and division and leading to cell ...synthesis and replication of DNA, for example: by ... See full document

6

Leptin receptor (Ob-R) mRNA expression and serum leptin concentration in patients with colorectal and metastatic colorectal cancer

Leptin receptor (Ob-R) mRNA expression and serum leptin concentration in patients with colorectal and metastatic colorectal cancer

... Colorectal cancer (CRC) is a commonly diagnosed cancer ...role in the growth of CRC ...protein and an adipose tissue- derived secreted protein that has been implicated primarily ... See full document

5

Environmentally compatible bioconjugated gold nanoparticles as efficient contrast agents for colorectal cancer cell imaging

Environmentally compatible bioconjugated gold nanoparticles as efficient contrast agents for colorectal cancer cell imaging

... ␤-catenin) and E-cadherin antibory (anti- E-cadherin) and applied them as novel contrast agents for the detection of colorectal cancerous cells with fluorescence confocal ...epithelial ... See full document

8

Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer

Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer

... LS174T and HCT116 cells incubated for 5 hours with both MF and MF-anti-CEA samples at a final iron concentration of 60 ng/ ...cultured cells were centrifuged (1000 g, 2 minutes) after trypsin ... See full document

12

Development and characterization of pH-sensitive fucoidan-chitosan nanoparticles for oral delivery of methotrexate to lung cancer cells

Development and characterization of pH-sensitive fucoidan-chitosan nanoparticles for oral delivery of methotrexate to lung cancer cells

... present in the structure, and pKa value close to 6, chitosan major drawback is its poor solubility at physiological pH values being positively charged in acidic environments and neutral ... See full document

99

Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells

Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells

... tumors and has significant dose-limiting ...proteins and rapid hepatic ...as delivery vehicles may improve the unfavorable pharmacokinetic properties of ...BTZ. In terms of cytotoxicity of ... See full document

18

Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.

Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.

... from colorectal cancer ...involved in tumor migration and metastasis. The role of OPN in cancer is currently ...unclear. In this study, OPN mRNA was examined in ... See full document

6

Role of PLCy1 in the resistance mechanism to Anti-EGFR therapy in metastatic colorectal cancer

Role of PLCy1 in the resistance mechanism to Anti-EGFR therapy in metastatic colorectal cancer

... treatment in our panel of CRC cells (Figure ...PLCγ1 and a lipase constitutively active mutant (PLCγ1 ΔSA) in this cell ...an in-frame deletion of γSA PLCγ1 region known to own ... See full document

61

Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells.

Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells.

... dynamics in EMT and suggesting that pharma- cological modulation of actin dynamics represents a valid approach to target EMT in ...The in vivo use of actin modulators such as cytochalasins, ... See full document

12

Development of new DODAX:MO:DC-Chol nanoparticles containing BRAF-siRNA for colorectal cancer therapy

Development of new DODAX:MO:DC-Chol nanoparticles containing BRAF-siRNA for colorectal cancer therapy

... Blot in order to confirm a technical problem in the siRNA oligos or in the ...apoptotic and proliferative ...incubate cells in the same the conditions of intestine and ... See full document

91

Differences in chemosensitivity between primary and metastatic tumors in colorectal cancer.

Differences in chemosensitivity between primary and metastatic tumors in colorectal cancer.

... digested in dispersion collagenase enzyme, and the dispersed cancer cells were incubated in a collagen gel-coated ...viable cells adhering to the collagen gel-layer were ... See full document

4

Targeting metastatic colorectal cancer with PLGA nanoparticles carrying MACC1 siRNA

Targeting metastatic colorectal cancer with PLGA nanoparticles carrying MACC1 siRNA

... proteins, and this feature is used as an advantage to artificially modify antibodies and another proteins of interest to produce the chemical conjugations desired through sulfhydryl binding reagents ... See full document

126

Functionalized gold nanoparticles improve afatinib delivery into cancer cells

Functionalized gold nanoparticles improve afatinib delivery into cancer cells

... The in vitro controlled release experiment of afatinib alone and afatinib conjugated with PEGAuNPs were investigated, as shown in Figure ...µM, in PBS ...20%, in contrast to almost all ... See full document

14

Mutational analysis of KRAS and NRAS in metastatic colorectal cancer

Mutational analysis of KRAS and NRAS in metastatic colorectal cancer

... found in cancer cells is typically associated with mutations in codons 12, 13 or 61, since these codons, located in the P-loop (codons 12 and 13) and in the switch ... See full document

88

Synthesis and evaluation of polymer nanoparticles for delivery in RPE cells

Synthesis and evaluation of polymer nanoparticles for delivery in RPE cells

... studied in 1996 by Hennink et al, which showed that this polymer had potential as a gene delivery system ...ends, and in different macromolecular architectures (such as block, star, and ... See full document

72

Show all 10000 documents...